Joel Rurik

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Journal article: NATURE CARDIOVASCULAR RESEARCH. 2025;4(4):353-355
Inflammatory CD248⁺ activated fibroblasts are a potential therapeutic target in ischemic heart disease
Rurik JG
Journal article: NATURE REVIEWS METHODS PRIMERS. 2024;4(1):74
Non-viral vectors for chimeric antigen receptor immunotherapy
Tretbar US; Rurik JG; Rustad EH; Sueruen D; Koehl U; Olweus J; Buchholz F; Ivics Z; Fricke S; Blache U
Journal article: MOLECULAR CELL. 2022;82(19):3613-3631.e7
Tissue-specific Grb10/Ddc insulator drives allelic architecture for cardiac development
Juan AM; Foong YH; Thorvaldsen JL; Lan Y; Leu NA; Rurik JG; Li L; Krapp C; Rosier CL; Epstein JA; Bartolomei MS
Journal article: DNA AND CELL BIOLOGY. 2022;41(6):539-543
Uniting Disciplines to Develop Therapeutics: Targeted mRNA Lipid Nanoparticles Reprogram the Immune System In Vivo to Treat Heart Disease
Rurik JG; Epstein JA
Journal article: NATURE METABOLISM. 2022;4(2):163-169
CAR-based therapies: opportunities for immuno-medicine beyond cancer
Aghajanian H; Rurik JG; Epstein JA
Journal article: SCIENCE. 2022;375(6576):91-96
CAR T cells produced in vivo to treat cardiac injury
Rurik JG; Tombacz I; Yadegari A; Fernandez POM; Shewale SV; Li L; Kimura T; Soliman OY; Papp TE; Tam YK; Mui BL; Albelda SM; Pure E; June CH; Aghajanian H; Weissman D; Parhiz H; Epstein JA
Journal article: CIRCULATION RESEARCH. 2021;128(11):1766-1779
Immune Cells and Immunotherapy for Cardiac Injury and Repair
Rurik JG; Aghajanian H; Epstein JA
Journal article: THESCIENCEBREAKER. 2020;06(02)
Taking cardiac fibrosis down with engineered immune cells
Rurik JG; Epstein JA
Journal article: NATURE. 2019;573(7774):430-433
Targeting cardiac fibrosis with engineered T cells
Aghajanian H; Kimura T; Rurik JG; Hancock AS; Leibowitz MS; Li L; Scholler J; Monslow J; Lo A; Han W; Wang T; Bedi K; Morley MP; Saldana RAL; Bolar NA; McDaid K; Assenmacher C-A; Smith CL; Wirth D; June CH; Margulies KB; Jain R; Pure E; Albelda SM; Epstein JA
Journal article: JOURNAL OF BIOLOGICAL CHEMISTRY. 2017;292(47):19266-19278
Proteolytic degradation of regulator of G protein signaling 2 facilitates temporal regulation of G_q/11 signaling and vascular contraction
Kanai SM; Edwards AJ; Rurik JG; Osei-Owusu P; Blumer KJ
Journal article: JOURNAL OF DEVELOPMENTAL BIOLOGY. 2015;3(4):93-111
Pbx4 is Required for the Temporal Onset of Zebrafish Myocardial Differentiation
Kao RM; Rurik JG; Farr GHIII; Dong XR; Majesky MW; Maves L

Alla övriga publikationer

Review: CARDIOLOGY PLUS. 2025;10(2):129-144
RNA-ssisting immunity to heal the heart: a new frontier in therapeutics
Rurik JG; Le Phu C; Mustroph J; Buggert M
Preprint: BIORXIV. 2025;BIORXIV
In vivo anti-FAP CAR T therapy reduces fibrosis and restores liver homeostasis in metabolic dysfunction-associated steatohepatitis.
Yashaswini CN; Cogliati B; Qin T; To T; Williamson T; Papp TE; Li K; Rasul R; Chen L; Lightstone A; Aghajanian H; Parhiz H; Wang S; Rurik JG; Epstein JA; Friedman SL

Anställningar

Anknuten till Forskning, Medicin, Huddinge, Karolinska Institutet, 2025-2026
Postdoktor, Medicin, Huddinge, Karolinska Institutet, 2023-2025

Artiklar

Alla övriga publikationer

Anställningar

Nyheter från KI

Kalenderhändelser från KI